Exclusive

Publication

Byline

Location

Kajima Corporation Q1 Income Climbs

India, Aug. 5 -- Kajima Corporation (KAJ.F) released a profit for its first quarter that Increased, from last year The company's earnings came in at JPY30.926 billion, or JPY66.57 per share. This com... Read More


Nippon Yusen Kabushiki Kaisha Announces Climb In Q1 Bottom Line

India, Aug. 5 -- Nippon Yusen Kabushiki Kaisha (NYKA.F) reported a profit for its first quarter that Increased, from the same period last year The company's earnings totaled JPY67.109 billion, or JPY... Read More


Procter & Gamble To Buy Health Firm Thorne From L Catterton For $3.8 Bln Cash

India, Aug. 5 -- L Catterton, a consumer-focused investment firm, announced late Tuesday that it has signed a definitive agreement to sell science-backed health and wellness firm Thorne to consumer go... Read More


Indian Shares Modestly Higher As RBI Holds Rates

India, Aug. 5 -- Indian shares opened on a positive note on Wednesday as crude oil prices slumped and global bond yields eased amid hopes for progress on opening the Strait of Hormuz. Investors were ... Read More


Kobe Steel Ltd. Reveals Fall In Q1 Bottom Line

India, Aug. 5 -- Kobe Steel Ltd. (KBSTY.PK) reported earnings for first quarter that Dropped, from last year The company's earnings totaled JPY12.199 billion, or JPY30.87 per share. This compares wit... Read More


Rhythm Q2 Loss Widens On Higher Expenses, Cuts Outlook For FY26 Operating Expense

India, Aug. 4 -- Rhythm Pharmaceuticals, Inc. (RYTM) on Tuesday reported a wider second-quarter net loss as higher operating expenses more than offset strong revenue growth, driven by increased global... Read More


Moderna Begins Phase 1 Trial Of MRNA-1469 Vaccine Targeting Budibugyo Ebola Virus

India, Aug. 4 -- Moderna Inc. (MRNA) has dosed the first participants in a Phase 1 clinical trial of its investigational vaccine mRNA- 1469, designed to prevent infection caused by Bundibugyo ebolavir... Read More


AbbVie Says Canada's Drug Agency Recommends Public Reimbursement Of UBRELVY For Migraine

India, Aug. 4 -- AbbVie Inc. (ABBV) announced on Tuesday that Canada's Drug Agency (CDA-AMC) has recommended public reimbursement of UBRELVY, for the acute treatment of migraine, with or without aura,... Read More


SIG H1 Loss Narrows

India, Aug. 4 -- SIG plc (SHI.L) on Tuesday reported a narrower loss for the first half of fiscal 2026. Total loss after tax for the period narrowed to 21.4 million pounds or 1.9 pence per share from... Read More


Nedbank Group Limited Profit Advances In H1

India, Aug. 4 -- Nedbank Group Limited (NCO.F) announced earnings for its first half that Increases, from last year The company's bottom line came in at ZAR8.354 billion, or ZAR17.92 per share. This ... Read More